Perfect Medical Health Management 1830.HK · HKD

Consumer Discretionary · HKEX · 🇭🇰 Hong Kong

Compare

1.20

+0.84%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2026

Revenue

HK$962.3m

FY2017FY2026

Net income

HK$178.7m

FY2017FY2026

Free cash flow

HK$309.2m

FY2017FY2026

Shareholders' equity

HK$387.9m

FY2017FY2026

Income statement

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	HK$962.3m	HK$1.13bn	HK$1.39bn	HK$1.39bn	HK$1.35bn	HK$1.09bn	HK$1.24bn	HK$1.20bn	HK$906.3m	HK$757.0m
Operating income	HK$216.3m	HK$251.6m	HK$382.4m	HK$368.8m	HK$383.8m	HK$302.9m	HK$453.8m	HK$395.9m	HK$236.3m	HK$117.7m
Net income	HK$178.7m	HK$206.9m	HK$315.8m	HK$315.6m	HK$305.2m	HK$284.6m	HK$360.2m	HK$319.0m	HK$194.2m	HK$91.4m
Diluted earnings per share	0.14	0.16	0.25	0.25	0.25	0.23	0.32	0.29	0.17	0.08

Balance sheet

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Total assets	HK$834.2m	HK$935.9m	HK$1.22bn	HK$1.30bn	HK$1.28bn	HK$1.48bn	HK$1.30bn	HK$855.4m	HK$818.5m	HK$738.0m
Cash and short-term investments	HK$294.9m	HK$386.8m	HK$567.4m	HK$656.8m	HK$454.4m	HK$532.9m	HK$668.2m	HK$457.9m	HK$419.9m	HK$315.9m
Total liabilities	HK$446.3m	HK$557.2m	HK$725.0m	HK$684.0m	HK$786.9m	HK$795.5m	HK$620.2m	HK$294.7m	HK$348.4m	HK$284.3m
Debt	HK$134.6m	HK$216.6m	HK$268.7m	HK$240.4m	HK$311.1m	HK$261.6m	HK$263.1m	−HK$116.3m	−HK$204.3m	−HK$173.3m
Shareholders' equity	HK$387.9m	HK$379.9m	HK$497.5m	HK$612.3m	HK$494.3m	HK$684.8m	HK$679.0m	HK$560.7m	HK$470.2m	HK$453.7m
Shares outstanding	1,256m	1,256m	1,256m	1,256m	1,241m	1,223m	1,117m	1,103m	1,112m	1,085m

Cash flow

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash from operations	HK$339.5m	HK$332.9m	HK$497.1m	HK$560.6m	HK$516.7m	HK$605.9m	HK$645.4m	HK$453.4m	HK$243.6m	HK$205.5m
Capital spending	−HK$30.3m	−HK$34.7m	−HK$54.2m	−HK$26.7m	−HK$144.6m	−HK$78.2m	−HK$96.4m	−HK$53.2m	−HK$37.7m	−HK$41.2m
Free cash flow	HK$309.2m	HK$298.2m	HK$442.9m	HK$533.8m	HK$372.2m	HK$527.7m	HK$549.0m	HK$400.2m	HK$205.9m	HK$164.3m
Dividends paid	−HK$162.0m	−HK$359.3m	−HK$391.9m	−HK$191.8m	−HK$405.5m	−HK$282.3m	−HK$218.8m	−HK$327.1m	−HK$186.2m	−HK$92.8m

Latest quarters

By quarter end

	Mar 2026	Sept 2025	Mar 2025	Sept 2024	Mar 2024	Sept 2023	Mar 2023	Sept 2022
Revenue	HK$476.5m	HK$485.9m	HK$507.6m	HK$620.3m	HK$675.2m	HK$718.1m	HK$721.0m	HK$668.3m
Operating income	HK$105.7m	HK$111.0m	HK$92.4m	HK$158.5m	HK$180.4m	HK$197.0m	HK$206.7m	HK$159.6m
Net income	HK$83.9m	HK$94.8m	HK$66.1m	HK$140.8m	HK$149.4m	HK$166.4m	HK$165.0m	HK$150.7m
Diluted earnings per share	0.07	0.08	0.05	0.11	0.12	0.13	0.13	0.12
Cash from operations	HK$183.0m	HK$156.0m	HK$130.0m	HK$203.0m	HK$209.0m	HK$288.0m	HK$261.0m	HK$298.0m
Capital spending	−HK$30.0m	—	−HK$34.0m	—	−HK$54.0m	—	−HK$26.0m	−HK$13.0m
Free cash flow	HK$153.0m	—	HK$96.0m	—	HK$155.0m	—	HK$235.0m	HK$285.0m
Total assets	HK$834.2m	HK$925.4m	HK$935.9m	HK$1.08bn	HK$1.22bn	HK$1.24bn	HK$1.30bn	HK$1.38bn
Cash and short-term investments	HK$294.9m	HK$425.0m	HK$386.8m	HK$471.4m	HK$567.4m	HK$632.3m	HK$656.8m	HK$633.8m
Debt	HK$58.4m	HK$177.1m	HK$216.6m	HK$238.7m	HK$268.7m	HK$212.8m	HK$240.4m	HK$241.9m
Shareholders' equity	HK$387.9m	HK$428.7m	HK$379.9m	HK$452.2m	HK$497.5m	HK$539.8m	HK$612.3m	HK$604.5m

Financial ratios

Data as of 2 Nov 2026

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021
Operating margin	22.5%	23.4%	28.3%	26.5%	28.4%	27.8%
Net margin	18.6%	18.3%	22.7%	22.7%	22.6%	26.1%
Return on equity	46.1%	54.5%	63.5%	51.6%	61.8%	41.6%
Return on assets	21.4%	22.1%	25.8%	24.3%	23.8%	19.2%
Free cash flow yield	26.3%	26.1%	39.2%	41.7%	47.6%	49.9%
Revenue growth	-14.7%	-19.1%	0.3%	2.9%	23.9%	-12.2%
Earnings growth	-13.6%	-34.5%	0.1%	3.4%	7.2%	-21.0%
Current ratio	1.06x	1.18x	1.35x	1.44x	0.97x	1.17x
Debt to equity	0.15x	0.26x	0.20x	0.19x	0.27x	0.15x
Equity ratio	46.5%	40.6%	40.7%	47.2%	38.6%	46.3%
Interest coverage	27.21x	23.80x	35.19x	29.45x	23.84x	23.04x
Buybacks as a share of market value	-0.0%	0.0%	0.0%	-1.2%	-1.5%	-9.5%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	-11.5%	-2.5%	0.9%
Operating income	-16.3%	-6.5%	3.0%
Net income	-17.3%	-8.9%	3.2%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Operating margin	22.4%	25.0%	26.1%	26.6%
Net margin	18.4%	20.9%	22.0%	22.0%

Valuation history

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Price to earnings	8.4	7.5	8.8	13.1	16.7	24.3	10.1	10.6	12.1	15.0
Price to sales	1.6	1.4	2.0	3.0	3.8	6.3	2.9	2.8	2.6	1.8

Dividends and splits

Per share, in the currency the company pays

Paid for 14 years. Last went ex-dividend on 14 Aug 2026.

	FY2027	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Paid in the year	0.07	0.129	0.261	0.255	0.201	0.297	0.42	0.144

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Perfect Medical Health Management 1830.HK · HKD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology